| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2796488 | Diabetes Research and Clinical Practice | 2013 | 7 Pages |
Abstract
The improvement in cerebral vasoreactivity in response to BHT after INDO administration suggests that the production of a vasoconstrictor metabolite of cyclooxygenase in diabetic patients was reduced by indomethacin consumption.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Vladimira Vuletic, Ines Drenjancevic, Dario Rahelic, Vida Demarin,